Pharmaceutical company Actavis PLC, based in Dublin, Ireland, with U.S. headquarters in Parsipanny, N.J., on Nov. 17 announced it has paid about $66 billion in cash and stock for Botox manufacturer Allergan Inc. in Irvine, Calif. Victor Lewkow and Paul Shim led a team from Cleary Gottlieb Steen & Hamilton in New York City, advising Actavis. Latham & Watkins represented Allergan in the transaction with a team led by Costa Mesa, Calif.-based partners Cary Hyden, Paul Tosetti and Michael Treska, along with a group from Wachtell, Lipton, Rosen & Katz in New York City, headed by Daniel Neff and David Katz.
Acquisition for York Risk Services
York Risk Services Group in Parsippany, N.J., on Nov. 17 announced its acquisition of fellow risk management service provider Risk Management Planning Group of Mineola, N.Y.
PDI Buys RedPath for $24.8M
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
